| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,242 |
18,912 |
$2.06M |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
21,567 |
16,176 |
$1.03M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
3,209 |
384 |
$433K |
| 90876 |
|
2,820 |
810 |
$232K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,607 |
8,271 |
$198K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
5,750 |
3,581 |
$123K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
4,804 |
3,423 |
$111K |
| 99205 |
Prolong outpt/office vis |
738 |
712 |
$105K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,387 |
597 |
$102K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,978 |
1,878 |
$89K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
1,567 |
1,320 |
$46K |
| Q3014 |
Telehealth originating site facility fee |
2,144 |
1,552 |
$13K |
| 99215 |
Prolong outpt/office vis |
127 |
115 |
$13K |
| 99306 |
Prolong nursin fac eval 15m |
122 |
109 |
$10K |
| 90834 |
Psychotherapy, 45 minutes with patient |
120 |
74 |
$8K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
94 |
94 |
$6K |
| T1016 |
Case management, each 15 minutes |
382 |
104 |
$6K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
23 |
12 |
$3K |
| 99305 |
|
20 |
20 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
38 |
31 |
$2K |
| 99335 |
|
46 |
28 |
$1K |
| 99336 |
|
16 |
12 |
$739.56 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
13 |
13 |
$298.50 |
| 96139 |
|
22 |
22 |
$215.33 |
| 96138 |
|
22 |
22 |
$215.33 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
285 |
246 |
$0.00 |
| 99407 |
|
28 |
26 |
$0.00 |